← FDA DRUG APPROVALS

FDA ANDA · ANDA086569

THEOCLEAR L.A.-130

Sponsor: SCHWARZ PHARMA

APPLICATION
ANDA086569
TYPE
ANDA
ROUTE
ORAL
DOSAGE FORM
CAPSULE, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

THEOCLEAR L.A.-130Discontinued
THEOPHYLLINE 130MG · CAPSULE, EXTENDED RELEASE · ORAL
THEOCLEAR L.A.-260Discontinued
THEOPHYLLINE 260MG · CAPSULE, EXTENDED RELEASE · ORAL
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →